These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). Eshleman SH; Krogstad P; Jackson JB; Wang YG; Lee S; Wei LJ; Cunningham S; Wantman M; Wiznia A; Johnson G; Nachman S; Palumbo P J Infect Dis; 2001 Jun; 183(12):1732-8. PubMed ID: 11372025 [TBL] [Abstract][Full Text] [Related]
28. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate. Manfredi R; Chiodo F J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549 [TBL] [Abstract][Full Text] [Related]
29. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Young J; Weber R; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC Antivir Ther; 2005; 10(5):585-91. PubMed ID: 16152752 [TBL] [Abstract][Full Text] [Related]
30. [Drug combination therapy for children infected with HIV/AIDS--own experience]. Prandota-Schoepp A; Klinowska-Skupniewska J Przegl Epidemiol; 2001; 55 Suppl 3():135-41. PubMed ID: 11984940 [TBL] [Abstract][Full Text] [Related]
31. Managing issues related to antiretroviral therapy. Lesho EP; Gey DC Am Fam Physician; 2003 Aug; 68(4):675-86. PubMed ID: 12952384 [TBL] [Abstract][Full Text] [Related]
32. A primer on AIDS drugs. AIDS Treatment Data Network AIDS Policy Law; 1996 Apr; 11(6):9. PubMed ID: 11363284 [TBL] [Abstract][Full Text] [Related]
34. Nelfinavir is number 4 -- but should it bat cleanup, or lead off? Mascolini M J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427 [TBL] [Abstract][Full Text] [Related]
35. [New antiretroviral agents]. Roca B; Simón E An Med Interna; 1998 Nov; 15(11):606-14. PubMed ID: 9882861 [TBL] [Abstract][Full Text] [Related]
36. Anti-HIV drugs. De Clercq E Verh K Acad Geneeskd Belg; 2007; 69(2):81-104. PubMed ID: 17550060 [TBL] [Abstract][Full Text] [Related]
37. ddI and d4T plus protease inhibitors. GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012 [TBL] [Abstract][Full Text] [Related]
38. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients? Cuzin L; Allavena C; Morlat P; Dellamonica P AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976 [TBL] [Abstract][Full Text] [Related]
39. Update from the 5th Conference on Retroviruses and Opportunistic Infections. Vazquez E Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483 [TBL] [Abstract][Full Text] [Related]